Patents by Inventor Scott Lauder

Scott Lauder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8338575
    Abstract: The invention is directed to a fusion protein which includes a first portion including an immunoglobulin (Ig) chain and a second portion including interleukin-7 (IL-7).
    Type: Grant
    Filed: May 18, 2011
    Date of Patent: December 25, 2012
    Assignee: Merck Patent GmbH
    Inventors: Scott Lauder, Stephen D. Gillies
  • Publication number: 20110243887
    Abstract: The invention is directed to a fusion protein which includes a first portion including an immunoglobulin (Ig) chain and a second portion including interleukin-7 (IL-7).
    Type: Application
    Filed: May 18, 2011
    Publication date: October 6, 2011
    Applicant: Merck Patent GmbH
    Inventors: Scott Lauder, Stephen D. Gillies
  • Patent number: 7960514
    Abstract: The invention is directed to a fusion protein which includes a first portion including an immunoglobulin (Ig) chain and a second portion including interleukin-7 (IL-7).
    Type: Grant
    Filed: December 4, 2007
    Date of Patent: June 14, 2011
    Assignee: Merck Patent GmbH
    Inventors: Scott Lauder, Stephen D. Gillies
  • Publication number: 20090092607
    Abstract: The present invention provides Fc-erythropoietin (“Fc-EPO”) fusion proteins with improved pharmacokinetics. Nucleic acids, cells, and methods relating to the production and practice of the invention are also provided.
    Type: Application
    Filed: September 26, 2008
    Publication date: April 9, 2009
    Applicant: Merck Patent GmbH
    Inventors: Stephen D. Gillies, Scott Lauder
  • Publication number: 20090010875
    Abstract: The invention is directed to a fusion protein which includes a first portion including an immunoglobulin (Ig) chain and a second portion including interleukin-7 (IL-7).
    Type: Application
    Filed: December 4, 2007
    Publication date: January 8, 2009
    Inventors: Scott Lauder, Stephen D. Gillies
  • Patent number: 7465447
    Abstract: The present invention provides Fc-erythropoietin (“Fc-EPO”) fusion proteins with improved pharmacokinetics. Nucleic acids, cells, and methods relating to the production and practice of the invention are also provided.
    Type: Grant
    Filed: December 30, 2004
    Date of Patent: December 16, 2008
    Assignee: Merck Patent GmbH
    Inventors: Stephen D. Gillies, Scott Lauder
  • Patent number: 7323549
    Abstract: The invention is directed to a fusion protein which includes a first portion including an immunoglobulin (Ig) chain and a second portion including interleukin-7 (IL-7).
    Type: Grant
    Filed: December 30, 2004
    Date of Patent: January 29, 2008
    Assignee: EMD Lexigen Research Center Corp.
    Inventors: Scott Lauder, Stephen D. Gillies
  • Publication number: 20050192211
    Abstract: The present invention provides Fc-erythropoietin (“Fc-EPO”) fusion proteins with improved pharmacokinetics. Nucleic acids, cells, and methods relating to the production and practice of the invention are also provided.
    Type: Application
    Filed: December 30, 2004
    Publication date: September 1, 2005
    Applicant: EMD Lexigen Research Center Corp.
    Inventors: Stephen Gillies, Scott Lauder
  • Publication number: 20050164352
    Abstract: The invention is directed to a fusion protein which includes a first portion including an immunoglobulin (Ig) chain and a second portion including interleukin-7 (IL-7).
    Type: Application
    Filed: December 30, 2004
    Publication date: July 28, 2005
    Applicant: EMD Lexigen Research Center Corp.
    Inventors: Scott Lauder, Stephen Gillies
  • Publication number: 20050069521
    Abstract: Disclosed are compositions and methods for enhancing the circulating half-life of interleukin-2 proteins.
    Type: Application
    Filed: August 27, 2004
    Publication date: March 31, 2005
    Applicant: EMD Lexigen Research Center Corp.
    Inventors: Stephen Gillies, Scott Lauder, Jeffrey Way